• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Important, 31-07-2026: Updates

    31-07-2026 | 07:19 pm

    Glenmark Pharmaceuticals reported strong Q1 results. Consolidated Revenue grew 23.1% to ₹4,018.5 Cr, with EBITDA at ₹804.8 Cr and PAT at ₹482.8 Cr. India, North America, and Emerging Markets saw robust growth. RYALTRIS and WINLEVI continue global expansion.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited